GetTopicDetailResponse(id=a1248224212, topicName=肺癌腦轉移, introduction=肺癌腦轉移, content=null, image=null, comments=2, allHits=1613, url=https://h5.medsci.cn/topic?id=82242, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=84377, tagList=[TagDto(tagId=84377, tagName=肺癌腦轉移)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2258283, encodeId=87782258283f4, content=<a href='/topic/show?id=a1248224212' target=_blank style='color:#2F92EE;'>#肺癌腦轉移#</a> <a href='/topic/show?id=1f883652ea9' target=_blank style='color:#2F92EE;'>#卡瑞利珠單抗#</a>, objectTitle=顱內(nèi)腫瘤進展或死亡風險降低55%！吳一龍教授點評：卡瑞利珠單抗聯(lián)合放化療方案有望成為肺癌腦轉移一線治療, objectType=article, longId=869059, objectId=dcd4869059e4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-doctor-hand-with-pen-BWV9L2K.jpg, objectUrl=/article/show_article.do?id=dcd4869059e4, replyNumber=0, likeNumber=33, createdTime=2025-03-29, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=dcd4869059e4, moduleTitle=顱內(nèi)腫瘤進展或死亡風險降低55%！吳一龍教授點評：卡瑞利珠單抗聯(lián)合放化療方案有望成為肺癌腦轉移一線治療, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=dcd4869059e4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231075, encodeId=efc022310e5a0, content=<a href='/topic/show?id=59344319511' target=_blank style='color:#2F92EE;'>#多學科治療#</a> <a href='/topic/show?id=a1248224212' target=_blank style='color:#2F92EE;'>#肺癌腦轉移#</a>, objectTitle=肺癌腦轉移治療策略大揭秘！一文讀懂, objectType=article, longId=846892, objectId=91968468923a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726800373067_8538692.png, objectUrl=/article/show_article.do?id=91968468923a, replyNumber=0, likeNumber=92, createdTime=2024-10-15, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=91968468923a, moduleTitle=肺癌腦轉移治療策略大揭秘！一文讀懂, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=91968468923a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2147057, encodeId=b78b214e05760, content=<a href='/topic/show?id=a1248224212' target=_blank style='color:#2F92EE;'>#肺癌腦轉移#</a><a href='/topic/show?id=11b910639831' target=_blank style='color:#2F92EE;'>#伏美替尼#</a><a href='/topic/show?id=089c5285629' target=_blank style='color:#2F92EE;'>#恩曲替尼#</a><a href='/topic/show?id=f4bd10639985' target=_blank style='color:#2F92EE;'>#Taletrectinib#</a><a href='/topic/show?id=384b8220449' target=_blank style='color:#2F92EE;'>#肺癌#</a>
, objectTitle=肺癌腦轉移治療有多款藥物，部分?顱內(nèi)疾病控制率高達100%！, objectType=article, longId=780798, objectId=ffc5e807982d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230707/5499d11091194d1281d1a41f8687b2f9.jpg, objectUrl=/article/show_article.do?id=ffc5e807982d, replyNumber=0, likeNumber=150, createdTime=2023-07-09, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ffc5e807982d, moduleTitle=肺癌腦轉移治療有多款藥物，部分?顱內(nèi)疾病控制率高達100%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ffc5e807982d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1194487, encodeId=f88c119448e91, content=<a href='/topic/show?id=a1248224212' target=_blank style='color:#2F92EE;'>#肺癌腦轉移#</a>mark down, objectTitle=肺癌腦轉移, objectType=topic, longId=82242, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=96, createdTime=2022-02-17, rootId=0, userName=huihui0728, userId=059a1620547, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
